Wed, February 27, 2013

by: WOPRAI

SGMS, KCLI, IN, ATRC, RLH, GCAP Expected To Be Down After Next Earnings Releases

by: WOPRAI

MHGC, ATEC, TEG, PRTS, CLNE, SD Expected To Be Down After Next Earnings Releases

by: WOPRAI

YORW, MSEX, CKP, OXF Expected To Be Down Before Next Earnings Releases

by: WOPRAI

XTXI, BPHX, SSRI, MCP, WR, FSCI Expected To Be Down After Next Earnings Releases

by: WOPRAI

GTY, ALSK, BID, GXP, IMMR, MDR Expected To Be Down After Next Earnings Releases

by: WOPRAI

Stephen Tanal Maintained (UNFI) at Hold with Decreased Target to $51 on, Feb 27th, 2013

by: WOPRAI

Sumant Kulkarni Upgraded (BIIB) to Strong Buy and Increased Target to $187 on, Feb 27th, 2013

by: WOPRAI

Michael Baker Maintained (BGFV) at Hold with Increased Target to $15 on, Feb 27th, 2013

by: WOPRAI

Ian Sealey Initiated (BMO) at Strong Buy and Held Target at $71 on, Feb 27th, 2013

by: WOPRAI

Brandon Couillard Maintained (BIO) at Strong Buy with Increased Target to $140 on, Feb 27th, 2013

by: WOPRAI

Toni Kaplan Maintained (VRSK) at Hold with Increased Target to $55 on, Feb 27th, 2013

by: WOPRAI

Chris Thompson Maintained (AG) at Buy with Decreased Target to $24 on, Feb 27th, 2013

Tue, February 26, 2013

by: WealthMakers

WEALTHMAKERS.COM Issues Bullish Research Reports on ADC, ARTC, ARTW, ATLS, CLNT, COST

by: WealthMakers

WEALTHMAKERS.COM Issues Bullish Research Reports on CVE, ETR, FE, IBN, KERX, KIRK

by: WealthMakers

WEALTHMAKERS.COM Issues Bullish Research Reports on MNOV, ODP, ORI, THM

by: WealthMakers

WEALTHMAKERS.COM Issues Bearish Research Reports on NBIX, PCCC, SAH, USMO, WIFI

by: WealthMakers

WEALTHMAKERS.COM Issues Bullish Research Reports on ALOG, APPY, ARLP, BJRI, CBI, CENTA

by: WealthMakers

WEALTHMAKERS.COM Issues Bullish Research Reports on CKH, CWZ, DE, DFS, EDN, EGAN

by: WealthMakers

WEALTHMAKERS.COM Issues Bullish Research Reports on EL, GCO, ITRI, ITUB, LNDC, MNTX

by: WealthMakers

WEALTHMAKERS.COM Issues Bullish Research Reports on PLCE, SQM, SQNS, UIS, UNTY, VSCI

by: WealthMakers

WEALTHMAKERS.COM Issues Bearish Research Reports on COT, DOV, F, FWV, HGR, MDH

by: WOPRAI

CVE SqueezeTrigger Price is $31.60. There is $130,058,760 That Short Sellers Still Need To Cover.

by: WOPRAI

Berry Petroleum Co (NYSE:BRY), Down By 18.04% ($8.47) From $46.950 After BUYINS.NET Report Predicted Weakness Before Earnings

by: WOPRAI

South Jersey Industries Inc (NYSE:SJI), Down By 8.07% ($4.46) From $55.260 After BUYINS.NET Report Predicted Weakness Before Ea

by: WOPRAI

Soltoro Ltd (NYSE:SOL), Down By 6.85% ($0.17) From $2.480 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish

by: WOPRAI

Transmontaigne Partners LP (NYSE:TLP), Down By 13.09% ($5.59) From $42.720 After BUYINS.NET Report Predicted Weakness Before Ea

by: WOPRAI

Uranium Energy Corp (AMEX:UEC), Down By 5.95% ($0.15) From $2.520 After BUYINS.NET Report Predicted Stock Would Go Down Due To

by: WOPRAI

Citi Trends Inc (NASDAQ:CTRN), Up By 18.17% ($1.85) From $10.180 After BUYINS.NET Report Predicted Strength Before Earnings

by: WOPRAI

MPG SqueezeTrigger Price is $2.63. There is $6,473,685 That Short Sellers Still Need To Cover.

by: WOPRAI

CBZ SqueezeTrigger Price is $6.32. There is $34,256,694 That Short Sellers Still Need To Cover.

by: WOPRAI

MNOV SqueezeTrigger Price is $2.84. There is $435,825 That Short Sellers Still Need To Cover.

by: WOPRAI

EXLP SqueezeTrigger Price is $22.82. There is $6,463,541 That Short Sellers Still Need To Cover.

Sumant Kulkarni Upgraded (BIIB) to Strong Buy and Increased Target to $187 on, Feb 27th, 2013

Sumant Kulkarni of Canaccord Genuity, Upgraded "Biogen Inc." (BIIB) to Strong Buy and Increased Target from $163 to $187 on, Feb 27th, 2013.

Sumant has made no other calls on BIIB in the last 4 months.



There are 4 other peers that have a rating on BIIB. Out of the 4 peers that are also analyzing BIIB, 2 agree with Sumant's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Christopher Raymond of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $166 on, Thursday, January 3rd, 2013
  • Jay Olson of "Oppenheimer" Maintained at Hold with Decreased Target to $141 on, Thursday, January 3rd, 2013


These are the ratings of the 2 analyists that currently disagree with Sumant

  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $185 on, Friday, February 8th, 2013
  • Andrew Peters of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $170 on, Wednesday, February 6th, 2013